BioSpace News Archive

Biotech Beach

Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Academy of Ophthalmology Annual Meeting

Glaukos Corporation announced today that its technologies will be featured in various scientific programming at the American Academy of Ophthalmology (AAO) annual meeting, being held September 30 - October 3, 2022 in Chicago, IL.

September 28, 2022
·
8 min read
Sernova to Participate in the Roth Inaugural Healthcare Opportunities Conference

Sernova Corp. today announced it will be presenting at the upcoming Roth Inaugural Healthcare Opportunities Conference being held in-person in New York, NY on October 6, 2022.

September 28, 2022
·
4 min read
Drug Development

Altimmune Announces First Dosing of All Subjects in Phase 2 MOMENTUM Trial of Pemvidutide in Subjects with Obesity or Overweight

Altimmune, Inc. today announced the completion of first dosing of all subjects in its Phase 2 MOMENTUM trial evaluating the safety and efficacy of pemvidutide 1 in subjects with obesity or overweight.

September 28, 2022
·
4 min read
Business

Cigna Transforms Care Experience for Patients With Complex Conditions With Launch of Full Spectrum, Cost-Saving Products

Cigna (NYSE:CI), a global health service company, unveiled Cigna Pathwell, a new, industry-leading suite of products that connects customers with quality care providers to help improve health outcomes and lower costs for customers, their families, and their employers.

September 28, 2022
·
5 min read
Business

Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company

Johnson & Johnson took another step forward in establishing two independent, market-leading companies with the announcement of Kenvue as the name for the planned New Consumer Health Company.

September 28, 2022
·
7 min read
BioMidwest

Monopar to Present at Roth Inaugural Healthcare Opportunities Conference

Monopar Therapeutics Inc. today announced that Chandler Robinson, MD, Monopar’s Chief Executive Officer, will present at the Roth Inaugural Healthcare Opportunities Conference.

September 28, 2022
·
1 min read
Business

Aquestive Therapeutics Enters License and Supply Agreement with Pharmanovia for Libervant™ (diazepam) Buccal Film for European and MENA Markets

Aquestive Therapeutics, Inc. today announced it has entered a license, and supply agreement for Libervant™ (diazepam) Buccal Film with Pharmanovia, a global lifecycle management healthcare company, for treatment of prolonged or acute, convulsive seizures.

September 28, 2022
·
9 min read
SAB Biotherapeutics Unveils New Data at ISIRV OPTIONS XI Conference Validating SAB-176 Proof of Concept in Reducing Viral Load and Improving Symptoms of Influenza

SAB Biotherapeutics released today new data presented at the Options for Control of Influenza (OPTIONS XI) conference, which is hosted by the International Society for Influenza and other Respiratory Virus Diseases.

September 28, 2022
·
8 min read
Rakovina Therapeutics Announces Upcoming Scientific Conference Presentations

Rakovina Therapeutics Inc. is pleased to announce two upcoming conference presentations.

September 28, 2022
·
4 min read
Business

Nuvectis Pharma Announces Formation of a Scientific Advisory Board

Nuvectis Pharma, Inc. today announced the formation of a Scientific Advisory Board (“SAB”) comprised of world-renowned experts in translational science and clinical research that will help guide the Company’s research and development strategy.

September 28, 2022
·
6 min read